AACR Special Conferences present unique opportunities to interact with the world’s leading experts and discuss the latest findings in rapidly developing areas of cancer research. Conferences are relatively small (150-400 attendees) to allow ample time for discussion and networking. The formal and informal discussions at these conferences lead to new collaborations among investigators around the world and major advances in knowledge.
AACR Special Conferences focus on emerging areas of cancer research each year with the typical program lasting two to four days. Recent programs have focused on cancer epigenetics, molecular epidemiology, EMT, protein translation, and cell death mechanisms. A recurring series of Special Conferences focuses on the basic, clinical, and translational aspects of various cancers, including breast, prostate, lung, and colon cancer. Programs typically feature several plenary sessions, one or two keynote talks from thought leaders in the field, and one or two poster sessions and social events for networking.
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.
Comments from recent Special Conferences:
- I thoroughly enjoyed this conference! It was very informative and well organized! The administration was helpful when I had an issue, and was very generous. It was a great conference. - Metabolism and Cancer, October 2011
- It was a pleasure - I've attended this conference in the past & it has enhanced my research & helped me acquire funding. - Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications, October 2011
- This is the highest quality conference that I have been to so far, I have learned a lot from the talks, and can't wait to test out some of the ideas when I go back to my lab later! - Stem Cells, Development, and Cancer, March 2011
- This was one of the few conferences I have attended that was actually worth the effort to get there and the amount of backed up work on my desk that I have to catch up on. - Targeting PI3K/mTOR Signaling in Cancer, February 2011